GPCR logo

Structure Therapeutics (GPCR) EBITDA

Annual EBITDA

-$102.48 M
-$50.20 M-96.01%

December 31, 2023


Summary


Performance

GPCR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGPCRprofitabilitymetrics:

Quarterly EBITDA

-$45.57 M
-$12.49 M-37.74%

September 30, 2024


Summary


Performance

GPCR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGPCRprofitabilitymetrics:

TTM EBITDA

-$141.37 M
-$19.50 M-16.01%

September 30, 2024


Summary


Performance

GPCR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGPCRprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

GPCR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-96.0%-74.8%-67.4%
3 y3 years-544.3%-74.8%-67.4%
5 y5 years-544.3%-74.8%-67.4%

GPCR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-172.4%at low-261.2%at low-970.3%at low
5 y5-year-544.3%at low-261.2%at low-970.3%at low
alltimeall time-544.3%at low-261.2%at low-970.3%at low

Structure Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$45.57 M(+37.7%)
-$141.37 M(+16.0%)
Jun 2024
-
-$33.08 M(+4.1%)
-$121.86 M(+6.3%)
Mar 2024
-
-$31.79 M(+2.8%)
-$114.69 M(+11.9%)
Dec 2023
-$102.48 M(+96.0%)
-$30.92 M(+18.6%)
-$102.48 M(+21.4%)
Sep 2023
-
-$26.07 M(+0.6%)
-$84.44 M(+18.9%)
Jun 2023
-
-$25.91 M(+32.4%)
-$70.99 M(+20.4%)
Mar 2023
-
-$19.58 M(+52.0%)
-$58.98 M(+12.8%)
DateAnnualQuarterlyTTM
Dec 2022
-$52.28 M(+39.0%)
-$12.88 M(+2.1%)
-$52.28 M(-0.6%)
Sep 2022
-
-$12.62 M(-9.2%)
-$52.61 M(+31.5%)
Jun 2022
-
-$13.90 M(+7.9%)
-$39.99 M(+53.3%)
Mar 2022
-
-$12.88 M(-2.5%)
-$26.09 M(+97.5%)
Dec 2021
-$37.62 M(+136.5%)
-
-
Dec 2021
-
-$13.21 M
-$13.21 M
Dec 2020
-$15.91 M
-
-

FAQ

  • What is Structure Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Structure Therapeutics?
  • What is Structure Therapeutics annual EBITDA year-on-year change?
  • What is Structure Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Structure Therapeutics?
  • What is Structure Therapeutics quarterly EBITDA year-on-year change?
  • What is Structure Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Structure Therapeutics?
  • What is Structure Therapeutics TTM EBITDA year-on-year change?

What is Structure Therapeutics annual EBITDA?

The current annual EBITDA of GPCR is -$102.48 M

What is the all time high annual EBITDA for Structure Therapeutics?

Structure Therapeutics all-time high annual EBITDA is -$15.91 M

What is Structure Therapeutics annual EBITDA year-on-year change?

Over the past year, GPCR annual EBITDA has changed by -$50.20 M (-96.01%)

What is Structure Therapeutics quarterly EBITDA?

The current quarterly EBITDA of GPCR is -$45.57 M

What is the all time high quarterly EBITDA for Structure Therapeutics?

Structure Therapeutics all-time high quarterly EBITDA is -$12.62 M

What is Structure Therapeutics quarterly EBITDA year-on-year change?

Over the past year, GPCR quarterly EBITDA has changed by -$19.50 M (-74.83%)

What is Structure Therapeutics TTM EBITDA?

The current TTM EBITDA of GPCR is -$141.37 M

What is the all time high TTM EBITDA for Structure Therapeutics?

Structure Therapeutics all-time high TTM EBITDA is -$13.21 M

What is Structure Therapeutics TTM EBITDA year-on-year change?

Over the past year, GPCR TTM EBITDA has changed by -$56.93 M (-67.42%)